|
Post by JHam on Apr 23, 2020 12:30:59 GMT
Now up 64% premarket. Amazing number they just reported in their update. Growth has gone from 26 to 40?? Hard to imagine this one staying a secret for much longer. Glad I bought back in the other day. Was hoping to add more, but it’s still the most I have ever owned if this stock.
Here’s a great post from the man, ecoethcon:
$CPAH Keep in mind that these are subs and as such much of the revenue will stay after the crisis and new subs will come in which just contributes to the ever increase in recurring revenues. Just a conservative run rate of 3.5M per quarter going forward and the 10x multiple being given to collaboration SaaS companies gives $140M market cap or around $20/share....it may not get there until a months more of good results...but that is the worth and the worth to a potential buyer...and at this point they would be short sighted to sell the company for anything like this valuation.
Several years ago people were talking about the company being bought out "cheap" for around $400M ...and the company has never had such good prospects!!!
Also now with the news out those who had "inside" info can load up legally.they were the most short sighted if they didn't the second the PR came out...all those employees and channel partners!!!
|
|
|
Post by JHam on Apr 23, 2020 12:43:34 GMT
Up 90% now. It will probably come back down to earth, but the news is so good it should be the catalyst to take this thing out of $4-5 permanently.
|
|
|
Post by JHam on Apr 23, 2020 13:23:59 GMT
Sold out completely with a 95% realized gain. The news is spectacular, I’m just not sure if the market will really understand that yet. Definitely will be looking to get back after this news once/if the dust settles. This trade was worth 4 months of living expenses for me. In crazy times like this when I’m not sure when I’ll get back to work, I had to pull the trigger.
|
|
|
Post by JHam on Apr 23, 2020 13:40:54 GMT
There is a wild battle going on right now, likely between shorts trying to cover, day traders, and new investors who are excited about the books. Heading back down to earth now as expected. Doesn’t matter what I think about the news. It only matters what I think the market thinks.
|
|
|
Post by JHam on May 5, 2020 5:04:13 GMT
After things settled back down to where I felt it was safe and the trees had shake out all the traders, I bought back it. Averaged at $2.98 with the biggest position I've ever held (1/3 of my total portfolio). There is just too much upside here, with very little downside, imo. The update from the other day put an end to any concerns about debt/cash flow. $4M in projected revenue this quarter (first time reporting revs) with 80-90% margins trading at $18M market cap? Come on... The e-learning solution which has been added to their website but not yet announced has the potential to add multiples upon multiples from current levels: counterpath.com/e-learning/I'll continue to add under $3 to have a long term core position and a trading position.
|
|
|
Post by lala212 on May 5, 2020 10:02:15 GMT
I am in as well at $3.02. Good luck and thanks for the tip.
|
|
|
Post by magnus123 on May 10, 2020 17:41:19 GMT
I got a message from InteractiveBrokers that another insider transaction happened on 5 May with 416 shares. Small size but still nice.
|
|
|
Post by JHam on Jun 2, 2020 3:34:03 GMT
I got a message from InteractiveBrokers that another insider transaction happened on 5 May with 416 shares. Small size but still nice. Downloads are up 254% the past 30 days according to this report Looking forward to the company's next report and hopefully some guidance. I continue to add here under $4 and it is by far my biggest holding at the moment: www.crunchbase.com/organization/counterpath#section-company-tech-stack-by-g2-stack
|
|
|
Post by magnus123 on Jun 2, 2020 10:12:17 GMT
Impressive numbers!
The recent climb was very nice. Do you have any idea on guidance for the fiscal year 2020? It's difficult for me to imagine a realistic revenue forecast. If they can hold the pace of the fourth quarter, this would be big.
|
|
|
Post by JHam on Jun 2, 2020 10:28:44 GMT
Impressive numbers! The recent climb was very nice. Do you have any idea on guidance for the fiscal year 2020? It's difficult for me to imagine a realistic revenue forecast. If they can hold the pace of the fourth quarter, this would be big. No, and that is the ultimate conundrum with this stock. We have no idea until they tell us. Like this deal with Honeywell for Smart Talk. This has the chance to be a massive hit. It's available for purchase now, but we have no idea how much it will turn into for CPAH. A lot of it (all of it?) has to do with not letting competitors get the upper hand, so I get that. Either way though, it's safe to say all of these projects are going to add multiples upon multiples to their revenue stream, in my opinion.
|
|
|
Post by JHam on Jun 2, 2020 14:14:46 GMT
On the rise again today. Just added again between $3.50-$3.58. My cost basis rose, but whatever, still crazy undervalued imo.
|
|
|
Post by JHam on Jun 9, 2020 16:58:30 GMT
It’s always nice when the founder of the company throws in a $1M every now and then. The o/s after this will be a whopping 6.4M finance.yahoo.com/news/counterpath-announces-private-placement-114500183.htmlCounterPath Announces Private Placement
ACCESSWIRE ACCESSWIRE•June 9, 2020 Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, BC / ACCESSWIRE / June 9, 2020 / CounterPath Corporation (CPAH)(PATH.TO) (the "Company" or "CounterPath"), a global provider of award-winning Unified Communications and Collaboration (UCC) solutions for enterprises and service providers, is pleased to announce a non-brokered brokered private placement of 284,902 shares of common stock (each, a "Share") of the Company at a price of US$3.51 for gross proceeds of US$1,000,006 (the "Offering"). The net proceeds from the Offering will be used to pay down Company debt and for general corporate purposes. Insiders of the Company will subscribe for an aggregate of 142,451 Shares. The Offering will constitute a related party transaction under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The issuance to the insiders will be exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 because neither the fair market value of the subject matter of the transaction nor the consideration paid exceeded 25% of the Company's market capitalization. All of the securities issued by the Company in connection with the Offering will be subject to a hold period expiring four months and one day after closing of the Offering under Canadian securities laws and a hold period under United States securities laws. None of the securities to be issued will be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.
|
|
|
Post by JHam on Jun 11, 2020 11:49:40 GMT
|
|
|
Post by JHam on Jun 11, 2020 12:10:53 GMT
CounterPath Announces Closing of Private PlacementNot for distribution to United States newswire services or for dissemination in the United States VANCOUVER, BC, Canada — June 11, 2020 — CounterPath Corporation (NASDAQ: CPAH) (TSX: PATH) (the “Company” or “CounterPath”), a global provider of award-winning Unified Communications and Collaboration (UCC) solutions for enterprises and service providers, today announced the closing of a non-brokered private placement of 284,902 shares of common stock (each, a “Share”) of the Company at a price of US$3.51 for gross proceeds of US$1,000,006 (the “Offering”).
The net proceeds from the Offering will be used to pay down Company debt and for general corporate purposes.
Wesley Clover International Corporation (“Wesley Clover”), the Company’s largest shareholder, and KMB Trac Two Holdings Ltd. (“KMB”), the Company’s second largest shareholder, each subscribed for an aggregate of 142,451 Shares. The Offering constituted a related party transaction under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The issuance to each of the insiders is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 because neither the fair market value of the subject matter of the transaction nor the consideration paid exceeded 25% of the Company's market capitalization. As the Offering is a related party transaction and was announced less than 21 days before its closing, MI 61-101 requires the Company to explain why the shorter period was reasonable or necessary in the circumstances. In the view of the Company it was necessary to immediately close the Offering and therefore, such shorter period was reasonable and necessary in the circumstances to maintain its listing on the NASDAQ Capital Market.
All of the securities issued by the Company in connection with the Offering will be subject to a hold period expiring on October 11, 2020 under Canadian securities laws and a hold period under United States securities laws. None of the securities to be issued will be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.
NASDAQ Compliance
As previously disclosed, on December 16, 2019, the Company received a letter from the listing qualifications department staff of the NASDAQ Stock Market (“NASDAQ”) notifying the Company that the stockholders' equity of $1,922,675, as reported in its Quarterly Report on Form 10-Q for the period ended October 31, 2019, was below the minimum stockholders' equity of $2,500,000. The minimum stockholders' equity of $2,500,000 is required for continued listing on the NASDAQ Capital Market as set forth in NASDAQ listing rule 5550(b)(1), and as of December 13, 2019, the Company did not meet the alternatives of market value of listed securities or net income from continuing operations.
As of June 11, 2020, the Company believes that it has regained compliance with the minimum stockholders’ equity requirement as a result of the closing of the Offering. NASDAQ will continue to monitor the Company’s ongoing compliance with the minimum stockholders’ equity requirement and, if at the time of its next periodic report the Company does not evidence compliance with the minimum stockholders’ equity requirement, the Company may be subject to delisting. There can be no assurance that the Company will be able to maintain compliance with the minimum stockholders’ equity requirement.
Early Warning Disclosure
Wesley Clover, located at 390 March Road, Suite 110, Kanata, Ontario, Canada K2K 0G7, purchased 142,451 Shares issued pursuant to the Offering for aggregate consideration of US$500,003 in reliance on the prospectus exemption contained in section 2.10 of National Instrument 45-106 Prospectus Exemptions. Dr. Terence H. Matthews, with a business address of 390 March Road, Suite 110, Kanata, Ontario, Canada K2K 0G7, owns 99.9999% of the issued and outstanding voting shares of Wesley Clover.
The Shares acquired by Wesley Clover pursuant to the Offering represent 2.3% of the Shares of the Company outstanding as of June 10, 2020 before completion of the Offering.
Following the acquisition by Wesley Clover, Wesley Clover owns 1,732,269 Shares on a fully diluted basis, including 83,157 Shares that may be acquired on the conversion of deferred share units (each, a “DSU”) of the Company (which DSU’s are held directly by Dr. Matthews).
The 1,732,269 Shares represent 26.8% of the Shares outstanding as of June 10, 2020 following completion of the Offering on a fully diluted basis, which includes 83,157 Shares that may be acquired on the conversion of DSUs.
Wesley Clover acquired the Shares of the Company for investment purposes. Wesley Clover intends to monitor the business and affairs of the Company, including its financial performance, and depending upon these factors, market conditions and other factors, Wesley Clover may acquire additional securities of the Company as it deems appropriate. Alternatively, Wesley Clover may dispose of some or all of the Shares in privately negotiated transactions or otherwise.
KMB, located at 3540 Morgan Creek Way, Surrey, British Columbia, Canada V3Z 0J7, purchased 142,451 Shares issued pursuant to the Offering for aggregate consideration of US$500,003 in reliance on the prospectus exemption contained in section 2.10 of National Instrument 45-106 Prospectus Exemptions. Karen Bruk is the sole shareholder of KMB. Karen Bruk also holds 115,800 Shares of the Company. Karen Bruk and Steven Bruk, Karen Bruk’s spouse, exercise shared investment power over the Shares of the Company held by Karen Bruk and KMB. Steven Bruk is the legal and beneficial owner of 58,647 Shares.
The Shares acquired by KMB pursuant to the Offering represent 2.3% of the Shares of the Company outstanding as of June 10, 2020 before completion of the Offering. Following the acquisition by KMB, KMB owns 1,304,204 Shares, including 115,800 Shares held directly by Karen Bruk. The 1,304,204 Shares represent 20.4% of the Shares outstanding as of June 10, 2020 following completion of the Offering. Including the 58,647 Shares held by Steven Bruk and 22,842 Shares that may be acquired on the conversion of DSUs held by Steven Bruk, the 1,385,693 Shares represent 21.6% of the Shares outstanding as of June 10, 2020 following completion of the Offering on a fully diluted basis.
KMB acquired the Shares of the Company for investment purposes. KMB intends to monitor the business and affairs of the Company, including its financial performance, and depending upon these factors, market conditions and other factors, KMB may acquire additional securities of the Company as it deems appropriate. Alternatively, KMB may dispose of some or all of the Shares in privately negotiated transactions or otherwise.
An early warning report in respect of the purchases by each of Wesley Clover and KMB will be filed with the relevant Canadian securities regulatory authorities. A copy of such reports may be obtained from SEDAR at www.sedar.com or by contacting David Karp at 604-628-9364.
About CounterPath
CounterPath Corporation (NASDAQ: CPAH) is revolutionizing how people communicate in today’s modern mobile workforce. Its award-winning Bria solutions for desktop and mobile devices enable organizations to leverage their existing PBX or hosted VoIP service to extend seamless and secure unified communications and collaboration to users regardless of their location and network. CounterPath technology meets the unique requirements of several industries, including contact center, retail, warehouse, hospitality, and healthcare verticals. Its solutions are deployed world-wide by 8x8, Airbnb, AmeriSave, BT, Citibank, Comcast, Fusion, Fuze, Liberty Global, Uber, Windstream and others. Learn more at counterpath.com and follow on Twitter @counterpath.
Contacts:
David Karp
Chief Executive Officer
Email: dkarp@counterpath.com
Tel: (604) 628-9364
|
|
|
Post by JHam on Jun 12, 2020 19:32:11 GMT
|
|
|
Post by magnus123 on Jun 12, 2020 19:40:49 GMT
It's wonderful. You must be happy too:) Last 20 Min will be interesting, regardless at which price CPAH closes today. What will happen at next Earnings Release???
|
|
|
Post by JHam on Jun 12, 2020 19:46:31 GMT
It's wonderful. You must be happy too:) Last 20 Min will be interesting, regardless at which price CPAH closes today. What will happen at next Earnings Release??? Thrilled. CPAH is now 60% of portfolio so when it jumped to $4.62 I almost screamed haha. It’s just a sign of things to come imo. I love how strong hands are accumulating shares. Yeah, I think I the rest of this year is going to be interesting! 😃
|
|
|
Post by magnus123 on Jun 12, 2020 19:51:26 GMT
60 is massive! It's only 30% in my portfolio, but still very nice. The volatility is so crazy. If it falls again lower, i will blow the position up to 50% of my portfolio.
I have the feeling that this stock will have a CATS run at some point. The big difference is, that we are already invested now and not at $8-9 like in CATS in 2018:)
|
|
|
Post by JHam on Jun 12, 2020 19:59:18 GMT
60 is massive! It's only 30% in my portfolio, but still very nice. The volatility is so crazy. If it falls again lower, i will blow the position up to 50% of my portfolio. I have the feeling that this stock will have a CATS run at some point. The big difference is, that we are already invested now and not at $8-9 like in CATS in 2018:) It’s already had two CATS-like runs (more actually) in the last 6 months. And that was before they became cash flow positive. Yeah, I am overexposed with this one, but I can’t help myself with this one, lol. They are still trading at only 2x TRAILING revenue. Whaat?
|
|
|
Post by magnus123 on Jun 12, 2020 20:31:20 GMT
I have no problem to be overexposed in a stock, when i am absolutely convinced. During the Corona Crash, i bought so much CATS shares that my portfolio was more than 70% CATS. It worked out very well:D
I have placed an AH order at $3.35. I completely missed the sell off... what a gift.
|
|